New improvements in the second-generation: better battery, app control, and more!

Recruiting participants in Boston at the Joslin Diabetes Center

Matchstick-sized device implanted under the skin every 6-12 months. New data in over 4,000 people demonstrates it is safe for heart health. Could it launch by late 2017?

What does A1c miss and what can we do about it?

Who is “closing the loop,” and how fast are they moving?

Tighter requirements for home meters. What does this mean for current and future blood glucose monitors?

Coming in 2-3 years. How will it give patients and providers better advice?

Adds waterproof, color screen, and remote meter bolus. Will it speed FDA review of the 670G hybrid closed loop?

Views on FDA regulation, pipeline updates, and first vs. next-generation systems.

No fingersticks needed? Plus, a look at the “thinnest CGM ever” from Dexcom and Verily

Launches in the next 12-18 months. What we’re excited about…!

TCOYD’s CGM Medicare Appeals Assistance Program may be able to help!

Details on monthly test strip subscription plan and our first impressions.

Glucose, food, exercise, and even DIY closed loop on the phone

The artificial pancreas is here for those willing to build their own; what can manufacturers learn from OpenAPS?

A1c cannot capture the whole picture – hypoglycemia, time in range, and quality of life add so much more!

How many people have type 1? What are the barriers to using new therapies? What outcomes matter beyond A1c?

Abbott’s free Android app for caregivers is now available

Understanding the UnitedHealthcare/Medtronic partnership in the context of the Affordable Care Act.

New OneTouch Reveal app works with Apple and Android phones. Plus, a future partnership to integrate WellDoc’s FDA-approved BlueStar software.